News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
AKKARAJU SRINIVAS
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/20/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/23/2019 |
4/A
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Bought 37,604 shares
@ $65.85, valued at
$2.5M
Bought 29,000 shares
@ $67.12, valued at
$1.9M
Bought 1,180 shares
@ $64.3, valued at
$75.9k
|
|
| 01/07/2019 |
4/A
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Aravive, Inc.|
Txns:
| Granted 4,688 options
@ $0 |
|
| 09/22/2017 |
4/A
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 22,000 options to buy
@ $0 |
|
| 01/11/2012 |
4/A
| AKKARAJU SRINIVAS (Director) has filed a Form 4 on SYNAGEVA BIOPHARMA CORP|
Txns:
| Granted 15,000 options to buy
@ $23, valued at
$345k
|
|
|
|